"We are bullish on ICL and consider it one of our top picks in Israel."
Higher margins in the refining segment yield higher net revenue from refining.
Both investment banks are upbeat about the company’s second half results.
Chairman and CEO Avraham Bigger: The restructuring program is making better progress than planned.
The blast at the Ramat Hovav facility sent a plume of toxic fumes into the air.
The company obtained $725 million in credit from a syndicate of banks.
The bank predicts that the company will post a net profit of $200.3 million on $1.98 billion revenue in 2007.
The investment house sees a possible upside, but the company share price is “simply higher than its value”.
The soluble NPK fertilizer production facility will have an initial production capacity of 10,000 tons a year, which will be sold throughout India.
Two new South African contracts are at substantially higher rates.
The investment house: Wait for the expected technical correction in order to increase the position in the share.
UBS gives Israel Chemicals a “Buy1” with a target price of NIS 39.
“The acquisition of Supresta will boost Israel Chemicals’ flame retardant profile.”
The company acquired Supresta for $352 million.
The agreement reflects a price increase of $50 per ton over last year's deal.
Merrill Lynch: Israel Chemicals exceeded our expectations top to bottom.